SCHEMBL16093290

SCHEMBL16093290

Nc1ccc(S(=O)(=O)NC2CCCCCCCCC2)cc1

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.79
KDM4E B2RXH2 1/20 0.79
RECQL P46063 1/20 0.79
ALDH1A1 P00352 8/20 0.70
CYP3A4 P08684 1/20 0.70
TSHR P16473 1/20 0.70
MAPK1 P28482 1/20 0.70
HTT P42858 1/20 0.70
LMNA P02545 3/20 0.64
HPGD P15428 1/20 0.64
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
GAA P10253 2/20 0.59
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13845977 1.00 SMN1; SMN2 (0.79) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL4068438 1.00 SMN1; SMN2 (0.79) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL4066993 0.98 SMN1; SMN2 (0.81) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL12418058 0.95 SMN1; SMN2 (0.71) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL5452364 0.95 SMN1; SMN2 (0.75) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL11253764 0.91 SMN1; SMN2 (0.65) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL4071039 0.91 SMN1; SMN2 (0.68) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
Toluene SCHEMBL27696348 0.88 ALDH1A1 (0.73) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL23093579 0.83 KDM4E (0.58) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4
SCHEMBL6191704 0.83 SMN1; SMN2 (0.58) SMN1; SMN2KDM4ERECQLALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841282-B2 Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-23 US disclosed